lipodystrophy

Documents about lipodystrophy

• Registry for Patients With Lipodystrophy#856781ClinicalTrials.gov
• Immunogenicity of Metreleptin in Patients With Generalized Lipodystrophy#869851ClinicalTrials.gov
• Efficacy and Safety of Mibavademab in Adult and Pediatric Patients With Generalized Lipodystrophy#838098ClinicalTrials.gov
• Leptin to Treat Lipodystrophy#411335ClinicalTrials.gov
• Low Energy Diet and Familial Partial Lipodystrophy#261421ClinicalTrials.gov
• Study of Reyataz in HIV-infected Patients With Lipodystrophy Syndrome#407851ClinicalTrials.gov
• Cyclophosphamide in the Treatment of Associated Acquired Lipodystrophy Syndrome With Type 1 Diabetes#859580ClinicalTrials.gov
• Cholic Acid for Hepatic Steatosis in Lipodystrophy#812566ClinicalTrials.gov
• Open-label Study to Evaluate Metreleptin in Patients With Partial Lipodystrophy#978960ClinicalTrials.gov
• Psychological Morbidity and Facial Volume in HIV Lipodystrophy: Quantification of Treatment Outcome#991747ClinicalTrials.gov
• Insulin Regulated Amino Peptidase in Patients With Familial Lipodystrophy of DUNNIGAN#411318ClinicalTrials.gov
• Identification of a New Gene Involved in Hereditary Lipodystrophy#882492ClinicalTrials.gov
• Epidemiological and clinical data from the European Lipodystrophy Registry#194454HAL (France)
• Prevalence of Lipodystrophy Syndrome and Its Role as Cause of Metabolic Disturbances#287427ClinicalTrials.gov
• Impact of Lipodystrophy on the Inflammatory State of Non-diabetic Dunnigan Reunion Island Subjects#837122ClinicalTrials.gov
• Adipocyte, Insulin-resistance and Immunity : Evaluation of Interleukin-7 in Lipodystrophy, Diabetes and Obesity#901854ClinicalTrials.gov
• HIV Infection And Metabolic Abnormalities Protocol 1 (HAMA001)#856739ClinicalTrials.gov
• Acquired facial lipoatrophy: A report of 3 cases with imaging features#654938S-Space: Seoul National University
• A Study to Examine the Effects of the Leptin Receptor (LEPR) Agonist Antibody REGN4461 in Adult Patients With Familial Partial Lipodystrophy (FPLD)#854579ClinicalTrials.gov
• Metabolic Abnormalities in HIV-infected Persons#28591ClinicalTrials.gov
• Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With Lipodystrophy#314262ClinicalTrials.gov
• Supplementary Figures#246341Figshare
• SIRT1 Serum Concentrations in Lipodystrophic Syndromes#308470IRIS
• Egrifta Replacement and Sleep Disordered Breathing#850584ClinicalTrials.gov
• Intraoperative Fluid Management of Liposuction , Cardiometry Versus Rohrich Formula#865636ClinicalTrials.gov
• Bone phenotype in familial partial lipodystrophy type 2: Insulin resistance and sclerostin#388157HAL (France)
• Growth Hormone Dynamics and Cardiac Steatosis in HIV#843237ClinicalTrials.gov
• Assess the Possibility of Diagnosing Diabetes and Rediabetes Following Oral Induced Hyperglycemia in Patients With Dunnigan's Partial Familial Lipodystrophy by Replacing 75 g of Glucose With a Standardized Carbohydrate Breakfast and Continuous Interstitial Monitoring Glucose)#877706ClinicalTrials.gov
• Exploratory Study of the Relationships Between the Biomarkers of Inflammation, Lipidome and Insulin Resistance and Disorders of Glycemic Regulation in a Cohort of Insulin-resistant Subjects Due to Excess Weight or Dunnigan's Lipodystrophy#979080ClinicalTrials.gov
• Combination of Insulin Sensitizer and Leptin as Treatment for the HAART -Induced Metabolic Syndrome#160307ClinicalTrials.gov
• Unraveling the natural history of lipodystrophy syndromes: insights from the prospective LD-Lync study.#409365NCBI PubMed Central
• Susceptibility to Infectious Diseases in obEsity: an endocRine trAnslational socioLogic Evaluation, "SIDERALE"#121402ClinicalTrials.gov
• Study to Evaluate the Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects With PL#300390ClinicalTrials.gov
• Effects of Short-term Growth Hormone in HIV-infected Patients#883731ClinicalTrials.gov
• Immune Response to Pneumococcal Vaccination in Aging HIV Positive Adults#991877ClinicalTrials.gov
• Detraining in People Living With HIV/AIDS#869444ClinicalTrials.gov
• Study of Growth Hormone Inhibition Using Pegvisomant in Severe Insulin Resistance#279676ClinicalTrials.gov
• Rôles enzymatiques et non enzymatiques de la lipase hormono-sensible sur le développement du tissu adipeux#350637HAL (France)
• Clinical Studies of Progeria#867130ClinicalTrials.gov
• P465L-PPARγ mutation confers partial resistance to the hypolipidemic action of fibrates#213180HAL (France)
• BASIC: Boosted Atazanavir or Saquinavir Induced Lipid Changes#893663ClinicalTrials.gov
• Lactate Metabolism Study in HIV Infected Persons#916728ClinicalTrials.gov
• Metformin and Rosiglitazone, Alone or in Combination, in HIV-Infected Patients With Insulin and Fat Abnormalities#180353ClinicalTrials.gov
• The Skin Barrier in Users of Diabetes Devices#979517ClinicalTrials.gov
• SHARE: Simple HAART With Abacavir, Reyataz, and Epivir#845713ClinicalTrials.gov
• for Adipose Tissue DIabetes VAriants (fATDIVA)#889780ClinicalTrials.gov
• Quality of Life, Sleep, and Biomarkers in People With HIV/AIDS#911821ClinicalTrials.gov
• Evaluating the Performance and Safety of the Medical Device Janesse in the Treatment of Facial Dermal Tissue Defects#851001ClinicalTrials.gov
• Proceedings of the annual meeting of the European Consortium of Lipodystrophies (ECLip), Pisa, Italy, 28–29 September 2023#220606HAL (France)
• Relationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDS#907362ClinicalTrials.gov